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Introduction
Microbiota Accessible Carbohydrates and Susceptibility to Clostridioides difficile Infection
Keegan Schuchart, Thomas Auchtung, and Jennifer Auchtung
 Department of Food Science and Technology, University of Nebraska-Lincoln, Lincoln NE USA
Results
The gastrointestinal (GI) microbiome in humans is instrumental in 
gut health and warding off disease. Loss of diversity in the GI 
microbiome can lead to colonization of gut pathogens. Commonly, 
antibiotic treatment will lead to loss of microbial diversity within the 
human GI tract and provide new niches for drug resistant 
pathogens. For example Clostridioides difficile has been found to 
be one of the pathogens that infects the GI tract following loss of 
microbiome diversity. For this reason it is important to investigate 
how microbiome diversity loss can be prevented or how diversity 
can be recovered following antibiotic treatment. Dietary 
supplemented  microbe accessible carbohydrates (MACs) were 
investigated for their ability to help the human microbiome resist 
loss of diversity during/following antibiotic treatment. 
Understanding how dietary MACs can aid in microbiome health 
could help reduce unnecessary side effects of antibiotics.
Research Questions
1. Does varying the concentration of MACs in medium influence 
composition of fecal microbial communities and susceptibility 
to C. difficile infection?
2. Which members of the GI microbiome respond to MACs?
How does the concentration of MACs influence composition of 
fecal microbial communities and susceptibility to C. difficile?
Model:  Experimental variables:
● Fecal samples tested:
○ 1 adult (18-65)
● Antibiotics (Abx) tested:
○ Cefaclor
○ Clindamycin
● Media tested:
○ Defined bioreactor medium (B; mimic conditions of colon) 
■ 0.2g/L each MAC (arabinogalactan, inulin, soluble starch)
○ B/4: B + 0.05 g/L each MAC
○ B* 4: B +0.8 g/L each MAC
● Samples collected:
○ Levels of C. difficile: day 0, 1, 3, 5, 7
■ Measured by selective plating
○ Microbiome composition: day -7, -2, 0, and day 1
■ Assessed by extracting DNA, amplifying V4 region of 16S rRNA 
gene, sequencing on Illumina MiSeq (2X250), and analyzing 
with Mothur
Experimental Approaches
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Fig 2. C. difficile colonization resistance is not 
significantly influenced by MAC concentration. C. 
difficile levels were measured at the indicated time 
points in Clostridium difficile Colonization occurred 
to the same degree in  BRMX and BRM+4. BRM-4 
colonization occurred in a different capacity leading 
to an investigation of the colony composition of 
reactors in the low MACs environment.
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• Although MACs influence overall community composition, the changes that they cause are not sufficient to restore colonization resistance to human fecal communities 
treated with clindamycin.
• Soluble starch promotes robust, dose-dependent stimulation of isolates in Ruminoccocaceae, Lachnospiraceae and a Clostridiaceae families.
• Most isolates exhibit enhanced growth in the presence of one type of MAC. Some isolates exhibit lower final OD600 values in the presence of MACs
• Further studies will be needed to determine if specific MAC inhibit growth or cause rapid robust growth with death phase/cell density loss by 24 hrs of growth
• Additional MACs will need to be tested to determine if they are able to restore C. difficile colonization resistance.
96-well Plate Configuration:
 
Overview:
1. Culture fecal sample in replicate  human fecal minibioreactors in baseline bioreactor medium
2. Shift communities to medium with variable MAC composition (n=6 replicates/media type)
3. Treat triplicate reactors with antibiotics
4. Challenge with C. difficile and monitor levels over time.
5. Assess changes in microbiome composition
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Minibioreactor arrays support growth of human 
fecal microbial communities over time
Experimental timeline:
Which members of the microbiome respond to MACs?
Overview:
1. Culture bacteria isolated from human fecal samples in different growth media containing MACs to 
determine whether they are capable of metabolizing MACs
a. Bacterial isolates were members of the Bacteroidaceae, Clostridaceae, and Ruminococcaceae 
families that are dominant members of human fecal samples.
Model:  
96-well absorbance spectrophotometer was used 
to assess growth after 24 hrs by measuring 
optical density at 600 nM (OD 600)
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Media type:
 
Media tested:
● Baseline medium with no MACs (B0)
● Baseline medium with 0.05 (BAr/4), 0.2 (BAr), or 0.8 (BAr*4) g/L arabinose
● Baseline medium with 0.05 (BIn/4), 0.2 (BIn), or 0.8 (BIn*4) g/L inulin
● Baseline medium with 0.05 (BSt/4), 0.2 (BSt) and 0.8 (BSt*4) g/L soluble starch
 
MAC concentration influences microbial community composition but does not C. difficile susceptibility
A.
C.
Fig 1. Effect of MAC concentration on microbial community structure in the presence and absence of antibiotic 
treatment. Microbes from a fecal sample were grown in replicate reactors containing baseline medium (B), baseline 
medium with ¼ concentration of MACs (B/4), and 4X concentration of MACs (B*4). Community composition was assessed 
at day -7, day -2  and day 0 relative to C. difficile challenge. Triplicate reactors for each condition were treated with 
clindamycin or mock-treated with water as a control. A. Alpha diversity of cultures (number of OTUs and Shannon 
diversity) B. Principle Coordinates Analysis of Bray-Curtis dissimilarities (A). C. Distribution of ten most-abundant bacterial 
classes in control and clindamycin-treated reactor communities.
MACs stimulate the  growth of some Clostridiaceae, 
Lachnospiraceae and Ruminococcaceae isolates
B.
Fig 3. Growth of isolates in media 
with variable MAC concentrations. 
These graphs represent final OD600 
values of isolates grown in triplicate in 
B0(-), or in B0 with increasing 
concentrations of arabinogalactan 
(+Ar; 0.05, 0.2, 0.8 g/L), inulin (+In; 
0.05, 0.2, 0.8 g/L) or soluble starch 
(+St, 0.05, 0.2, 0.8 g/L). Asterisks 
indicate conditions that were both 
statistically significant from growth in 
B0 (two-tailed student’s t-test) and 
had an increased/decreased relative 
to value in B0 by >1.5-fold. 
Conclusions and Future Directions
